Please enable JavaScript to continue using this application.

Compare $ANNX vs $SLDB | Chartloom

Compare

$ANNX vs $SLDB

Annexon Inc · Solid Biosciences Inc

ANNX

Annexon Inc

SLDB

Solid Biosciences Inc

Compare $ANNX vs $SLDB

Comparing Annexon Inc and Solid Biosciences Inc

ANNXAnnexon Inc

SLDBSolid Biosciences Inc

ANNXAnnexon Inc

Market cap

$659M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

21.66x

Rev growth (TTM)

—

YTD performance

-14.3%

52W performance

27.6%

FCF yield

-29.3%

SLDBSolid Biosciences Inc

Market cap

$676M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

26.1%

52W performance

8.9%

FCF yield

-27.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ANNX

SLDB

Detailed metrics comparison

ANNX

Annexon Inc

SLDB

Solid Biosciences Inc

Market Cap

ANNX$659M

SLDB$676M

Enterprise Value

ANNX$459M

SLDB$517M

Price

ANNX$4.02

SLDB$6.87

P/E Ratio

ANNXN/A

SLDBN/A

P/S Ratio

ANNX0.00x

SLDB49.66x

EV/Sales

ANNX0.00x

SLDB38.88x

EV/EBITDA

ANNX0.00x

SLDB0.00x

P/B Ratio

ANNX4.27x

SLDB1.96x

P/FCF Ratio

ANNXN/A

SLDBN/A

EV/FCF

ANNX-2.38x

SLDB-2.75x

PEG Ratio

ANNXN/A

SLDBN/A

Forward P/E (NTM)

ANNXN/A

SLDBN/A

Forward P/S (NTM)

ANNX21.66x

SLDBN/A

Revenue (TTM)

ANNX$0

SLDB$0

Revenue Growth (YoY)

ANNXN/A

SLDBN/A

Forward Rev Growth

ANNX370.6%

SLDB822.7%

Gross Margin (TTM)

ANNX0.0%

SLDB0.0%

Operating Margin (TTM)

ANNX0.0%

SLDB0.0%

EBITDA Margin (TTM)

ANNX0.0%

SLDB0.0%

Net Margin (TTM)

ANNX0.0%

SLDB0.0%

FCF Margin (TTM)

ANNXN/A

SLDBN/A

Net Income (TTM)

ANNX$-203M

SLDB$-207M

FCF (TTM)

ANNX$-193M

SLDB$-188M

EPS (TTM)

ANNX-$1.01

SLDB-$1.44

ROE (TTM)

ANNX-10615.0%

SLDB-7228.0%

ROA (TTM)

ANNX-7982.0%

SLDB-6137.0%

ROIC (TTM)

ANNX-10615.0%

SLDB-7226.0%

Cash

ANNX$199M

SLDB$159M

Debt

ANNX$0

SLDB$0

Net Cash/Debt

ANNX$199M

SLDB$159M

Current Ratio (TTM)

ANNX5.53x

SLDB13.82x

Quick Ratio (TTM)

ANNX5.44x

SLDB13.24x

Debt/Equity (TTM)

ANNX0.00x

SLDB0.00x

Debt/Assets (TTM)

ANNX0.0%

SLDB0.0%

Interest Coverage (TTM)

ANNXN/A

SLDBN/A

Net Debt/EBITDA (TTM)

ANNX0.00x

SLDB0.00x

Beta

ANNX1.40

SLDB2.60

52W Performance

ANNX27.6%

SLDB8.9%

YTD Performance

ANNX-14.3%

SLDB26.1%

% from 52W High

ANNX-44.0%

SLDB-40.0%

% from 52W Low

ANNX58.3%

SLDB81.3%

Asset Turnover (TTM)

ANNX0.00x

SLDB0.07x

FCF Yield (TTM)

ANNX-29.3%

SLDB-27.8%

Earnings Yield (TTM)

ANNX-30.8%

SLDB-30.6%

Dividend Yield (TTM)

ANNXN/A

SLDBN/A

Rule of 40

ANNX0.0

SLDB0.0

EV/GP/RG

ANNXN/A

SLDBN/A

Ticker research

View ANNX research View SLDB research

Metric	ANNX Annexon Inc	SLDB Solid Biosciences Inc
Market & Valuation
Market Cap	$659M	$676M
Enterprise Value	$459M	$517M
Price	$4.02	$6.87
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	49.66x
EV/Sales	0.00x	38.88x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.27x	1.96x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.38x	-2.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	21.66x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	370.6%	822.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-203M	$-207M
FCF (TTM)	$-193M	$-188M
EPS (TTM)	-$1.01	-$1.44
ROE (TTM)	-10615.0%	-7228.0%
ROA (TTM)	-7982.0%	-6137.0%
ROIC (TTM)	-10615.0%	-7226.0%
Financial Health
Cash	$199M	$159M
Debt	$0	$0
Net Cash/Debt	$199M	$159M
Current Ratio (TTM)	5.53x	13.82x
Quick Ratio (TTM)	5.44x	13.24x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.40	2.60
52W Performance	27.6%	8.9%
YTD Performance	-14.3%	26.1%
% from 52W High	-44.0%	-40.0%
% from 52W Low	58.3%	81.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.07x
FCF Yield (TTM)	-29.3%	-27.8%
Earnings Yield (TTM)	-30.8%	-30.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ANNX research	View SLDB research

Valuation

P/S Ratio

ANNX

0.00x

SLDB

49.66x

EV/FCF

SLDB

-2.75x

ANNX

-2.38x

Growth & revenue

Forward Revenue Growth

SLDB

822.7%

ANNX

370.6%

Profitability & performance

Gross Margin

ANNX

0.0%

SLDB

0.0%

ROE

SLDB

-7228.0%

ANNX

-10615.0%

FCF Yield %

SLDB

-27.8%

ANNX

-29.3%

52-Week Performance

ANNX

27.6%

SLDB

8.9%

Detailed metrics comparison

ANNX

Annexon Inc

SLDB

Solid Biosciences Inc

Market Cap

ANNX$659M

SLDB$676M

Enterprise Value

ANNX$459M

SLDB$517M

Price

ANNX$4.02

SLDB$6.87

P/E Ratio

ANNXN/A

SLDBN/A

P/S Ratio

ANNX0.00x

SLDB49.66x

EV/Sales

ANNX0.00x

SLDB38.88x

EV/EBITDA

ANNX0.00x

SLDB0.00x

P/B Ratio

ANNX4.27x

SLDB1.96x

P/FCF Ratio

ANNXN/A

SLDBN/A

EV/FCF

ANNX-2.38x

SLDB-2.75x

PEG Ratio

ANNXN/A

SLDBN/A

Forward P/E (NTM)

ANNXN/A

SLDBN/A

Forward P/S (NTM)

ANNX21.66x

SLDBN/A

Revenue (TTM)

ANNX$0

SLDB$0

Revenue Growth (YoY)

ANNXN/A

SLDBN/A

Forward Rev Growth

ANNX370.6%

SLDB822.7%

Gross Margin (TTM)

ANNX0.0%

SLDB0.0%

Operating Margin (TTM)

ANNX0.0%

SLDB0.0%

EBITDA Margin (TTM)

ANNX0.0%

SLDB0.0%

Net Margin (TTM)

ANNX0.0%

SLDB0.0%

FCF Margin (TTM)

ANNXN/A

SLDBN/A

Net Income (TTM)

ANNX$-203M

SLDB$-207M

FCF (TTM)

ANNX$-193M

SLDB$-188M

EPS (TTM)

ANNX-$1.01

SLDB-$1.44

ROE (TTM)

ANNX-10615.0%

SLDB-7228.0%

ROA (TTM)

ANNX-7982.0%

SLDB-6137.0%

ROIC (TTM)

ANNX-10615.0%

SLDB-7226.0%

Cash

ANNX$199M

SLDB$159M

Debt

ANNX$0

SLDB$0

Net Cash/Debt

ANNX$199M

SLDB$159M

Current Ratio (TTM)

ANNX5.53x

SLDB13.82x

Quick Ratio (TTM)

ANNX5.44x

SLDB13.24x

Debt/Equity (TTM)

ANNX0.00x

SLDB0.00x

Debt/Assets (TTM)

ANNX0.0%

SLDB0.0%

Interest Coverage (TTM)

ANNXN/A

SLDBN/A

Net Debt/EBITDA (TTM)

ANNX0.00x

SLDB0.00x

Beta

ANNX1.40

SLDB2.60

52W Performance

ANNX27.6%

SLDB8.9%

YTD Performance

ANNX-14.3%

SLDB26.1%

% from 52W High

ANNX-44.0%

SLDB-40.0%

% from 52W Low

ANNX58.3%

SLDB81.3%

Asset Turnover (TTM)

ANNX0.00x

SLDB0.07x

FCF Yield (TTM)

ANNX-29.3%

SLDB-27.8%

Earnings Yield (TTM)

ANNX-30.8%

SLDB-30.6%

Dividend Yield (TTM)

ANNXN/A

SLDBN/A

Rule of 40

ANNX0.0

SLDB0.0

EV/GP/RG

ANNXN/A

SLDBN/A

Ticker research

View ANNX research View SLDB research

Metric	ANNX Annexon Inc	SLDB Solid Biosciences Inc
Market & Valuation
Market Cap	$659M	$676M
Enterprise Value	$459M	$517M
Price	$4.02	$6.87
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	49.66x
EV/Sales	0.00x	38.88x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.27x	1.96x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.38x	-2.75x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	21.66x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	370.6%	822.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-203M	$-207M
FCF (TTM)	$-193M	$-188M
EPS (TTM)	-$1.01	-$1.44
ROE (TTM)	-10615.0%	-7228.0%
ROA (TTM)	-7982.0%	-6137.0%
ROIC (TTM)	-10615.0%	-7226.0%
Financial Health
Cash	$199M	$159M
Debt	$0	$0
Net Cash/Debt	$199M	$159M
Current Ratio (TTM)	5.53x	13.82x
Quick Ratio (TTM)	5.44x	13.24x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.40	2.60
52W Performance	27.6%	8.9%
YTD Performance	-14.3%	26.1%
% from 52W High	-44.0%	-40.0%
% from 52W Low	58.3%	81.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.07x
FCF Yield (TTM)	-29.3%	-27.8%
Earnings Yield (TTM)	-30.8%	-30.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ANNX research	View SLDB research